Ironwood pharmaceuticals news
WebApr 11, 2024 · On April 10, 2024, Ironwood Pharmaceuticals, Inc. determined to eliminate the role of chief operating officer to streamline the executive leadership team. Accordingly, Jason Rickard's last day as Senior Vice President, Chief Operating Officer, and as an employee of the Company, will be May 12, 2024. WebApr 14, 2024 · Ironwood Pharmaceuticals Stock Performance IRWD opened at $11.10 on Friday. The stock has a market capitalization of $1.71 billion, a PE ratio of 11.44 and a beta of 0.95. Ironwood Pharmaceuticals, Inc. has a one year low …
Ironwood pharmaceuticals news
Did you know?
WebJan 4, 2024 · Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results February 13, 2024 Ironwood Pharmaceuticals Announces FDA Filing Acceptance and … WebMar 2, 2024 · Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Could Be 40% Below Their Intrinsic Value Estimate Simply Wall St March 2, 2024, 7:09 AM · 6 min read Key Insights The projected fair value...
Web1 day ago · Ironwood Pharmaceuticals Reports Strong Third Quarter 2024 Results; Maintains Full Year 2024 Financial Guidance. BOSTON--(BUSINESS WIRE)--Ironwood …
WebJan 9, 2024 · Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) shares are trading lower by 10.00% to $11.30 Monday afternoon after the company cut its FY22 sales guidance below … WebApr 13, 2024 · 2024-23 Season Snow: 220.1 inches 2024-22 Season Snow: 182.3 2024-21 Season Snow: 84.4 2024-20 Season Snow: 169.3 2024-19 Season Snow: 182.8
WebApr 12, 2024 · Shares of IRWD opened at $10.77 on Wednesday. Ironwood Pharmaceuticals, Inc. has a 1 year low of $9.73 and a 1 year high of $12.66. The company has a market cap of $1.66 billion, a price-to ...
WebApr 14, 2024 · Ironwood Pharmaceuticals had a net margin of 42.64% and a return on equity of 30.49%. The business had revenue of $107.20 million during the quarter, compared to analyst estimates of $108.23... dickman\\u0027s activated pony lardWebMar 9, 2024 · Ironwood Pharmaceuticals News More News Seeking Alpha 22d Ironwood Pharmaceuticals Non-GAAP EPS of $0.27 beats by $0.01, revenue of $107.2M misses by $1.02M, guidance in-line citroen.be navigationWebApr 15, 2024 · As a group, sell-side analysts forecast that Ironwood Pharmaceuticals, Inc. will post 1.06 earnings per share for the current fiscal year. Insider Transactions at Ironwood Pharmaceuticals. In other news, CEO Thomas A. Mccourt sold 46,129 shares of the business’s stock in a transaction that occurred on Monday, March 27th. The stock was … dickman the syringe driverWeb2 days ago · Ironwood Pharmaceuticals IRWD rose 3.4% amid speculation about an activist investor in the gastro intestinal drug company.; Gordon Haskett in a note on Thursday … citroen battle east sussexWebApr 10, 2024 · Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics... citroen berlingo 130 cv 1.2 forumWebIt is hard to get excited after looking at Ironwood Pharmaceuticals' (NASDAQ:IRWD) recent performance, when its stock... Zacks Strength Seen in Xencor (XNCR): Can Its 5.3% Jump … citroen benfica oficinaWebApr 14, 2024 · In other Ironwood Pharmaceuticals news, COO Jason Rickard sold 16,746 shares of the stock in a transaction on Monday, February 27th. The shares were sold at an average price of $11.41, for a total ... dickman\\u0027s function